生理学或影像学指导中等程度冠状动脉狭窄的治疗策略
本研究基于FLAVOUR随机临床试验的队列数据,纳入1619例患者共1753条中等程度冠状动脉狭窄血管,比较FFR指导与IVUS指导策略下推迟血运重建和已血运重建血管的2年靶血管失败(TVF)率。结果显示,推迟血运重建的950条血管中,IVUS组与FFR组TVF发生率相当(3.8% vs 4.1%,P=0.72);已血运重建的803条血管中两组TVF发生率亦相当(3.6% vs 3.7%,P=0.95)。FFR>0.92、MLA>4.5 mm²或PB≤58%可识别低风险推迟血管(HR 0.25,95%CI 0.09-0.71,P=0.009);术后FFR≤0.80、最小支架面积≤6.0 mm²或支架边缘PB>58%则与TVF风险升高相关(HR 7.20,95%CI 3.20-16.21,P<0.001)。
要点
- 推迟血运重建的950条血管中,IVUS指导组与FFR指导组2年TVF发生率相当(3.8% vs 4.1%,P=0.72)。
- 已血运重建的803条血管中,IVUS指导组与FFR指导组2年TVF发生率相当(3.6% vs 3.7%,P=0.95),接受PCI优化的血管中亦相似(4.2% vs 2.5%,P=0.31)。
- FFR指导组中FFR>0.92、IVUS指导组中MLA>4.5 mm²或PB≤58%的推迟血管TVF风险降低(HR 0.25,95%CI 0.09-0.71,P=0.009)。
- FFR指导组术后FFR≤0.80、IVUS指导组最小支架面积≤6.0 mm²或支架边缘PB>58%的血管TVF风险升高(HR 7.20,95%CI 3.20-16.21,P<0.001)。
适用人群与场景
- 来自FLAVOUR试验的中等程度冠状动脉狭窄患者,共1619例、1753条血管;平均(SD)年龄65.1(9.6)岁,男性1137例(70.2%)。
诊断标准与关键阈值
- IVUS指导策略推荐PCI的标准为最小管腔面积(MLA)≤3 mm²,或MLA 3 mm²至4 mm²且斑块负荷(PB)≥70%。
- FFR指导策略推荐PCI的标准为FFR≤0.80。
- 低风险推迟血管的识别标准:FFR指导组FFR>0.92;IVUS指导组MLA>4.5 mm²或PB≤58%。
- 高风险已血运重建血管的识别标准:FFR指导组术后FFR≤0.80;IVUS指导组最小支架面积≤6.0 mm²或支架边缘PB>58%。
红旗征与不能漏的情况
- 术后FFR≤0.80、最小支架面积≤6.0 mm²或支架边缘PB>58%的已血运重建血管,TVF风险升高(HR 7.20,95%CI 3.20-16.21,P<0.001)。
研究设计与关键结果
- 研究类型为基于FLAVOUR随机临床试验的队列研究;FLAVOUR为研究者发起的前瞻性、开放标签、多中心随机临床试验。
- 共纳入1619例患者(平均年龄65.1岁,男性70.2%)的1753条血管。
- 推迟血运重建的950条血管中,IVUS指导组与FFR指导组TVF发生率相当(3.8% vs 4.1%,P=0.72)。
- FFR指导组FFR>0.92、IVUS指导组MLA>4.5 mm²或PB≤58%的推迟血管TVF风险降低(HR 0.25,95%CI 0.09-0.71,P=0.009)。
- 已血运重建的803条血管中,IVUS指导组与FFR指导组TVF发生率相当(3.6% vs 3.7%,P=0.95);接受PCI优化的血管中亦相似(4.2% vs 2.5%,P=0.31)。
- FFR指导组术后FFR≤0.80、IVUS指导组最小支架面积≤6.0 mm²或支架边缘PB>58%的血管TVF风险升高(HR 7.20,95%CI 3.20-16.21,P<0.001)。
证据类型、等级与局限
- 证据类型:基于随机临床试验的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在中等程度冠状动脉狭窄患者中,FFR指导与IVUS指导策略在推迟血运重建和已血运重建血管中的2年TVF发生率均相当。
- FFR指导组FFR>0.92、IVUS指导组MLA>4.5 mm²或PB≤58%可识别低风险推迟血管,其TVF风险降低(HR 0.25,95%CI 0.09-0.71,P=0.009)。
- FFR指导组术后FFR≤0.80、IVUS指导组最小支架面积≤6.0 mm²或支架边缘PB>58%的已血运重建血管TVF风险升高(HR 7.20,95%CI 3.20-16.21,P<0.001)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies.
OBJECTIVES: To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] ≤3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] ≥70%) or an FFR-guided strategy (which recommended PCI for FFR ≤0.80). Data were analyzed from November to December 2022.
EXPOSURES: FFR or IVUS parameters within the deferred and revascularized vessels.
MAIN OUTCOMES AND MEASURES: The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years.
RESULTS: A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001).
CONCLUSIONS AND RELEVANCE: In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.
参考来源
- Yang S, Kang J, Hwang D, et al. Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis. JAMA Netw Open. 2024. PMID: 38170524. doi:10.1001/jamanetworkopen.2023.50036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。